Medicamen Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 435.41 million compared to INR 335.32 million a year ago. Revenue was INR 440.91 million compared to INR 340.57 million a year ago. Net income was INR 15.14 million compared to INR 36.04 million a year ago. Basic earnings per share from continuing operations was INR 1.17 compared to INR 2.85 a year ago. Diluted earnings per share from continuing operations was INR 1.17 compared to INR 2.85 a year ago.
For the six months, sales was INR 854.85 million compared to INR 666.2 million a year ago. Revenue was INR 864.14 million compared to INR 681.07 million a year ago. Net income was INR 56.91 million compared to INR 71.9 million a year ago. Basic earnings per share from continuing operations was INR 4.29 compared to INR 5.68 a year ago. Diluted earnings per share from continuing operations was INR 4.29 compared to INR 5.68 a year ago.